Cargando…
Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441540/ https://www.ncbi.nlm.nih.gov/pubmed/37608789 http://dx.doi.org/10.3389/fendo.2023.1253675 |
| _version_ | 1785093395287375872 |
|---|---|
| author | De Sousa-Coelho, A. L. Rodriguez-Rodriguez, R. Softic, S. Jonker, J. W. Relat, J. |
| author_facet | De Sousa-Coelho, A. L. Rodriguez-Rodriguez, R. Softic, S. Jonker, J. W. Relat, J. |
| author_sort | De Sousa-Coelho, A. L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10441540 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104415402023-08-22 Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans De Sousa-Coelho, A. L. Rodriguez-Rodriguez, R. Softic, S. Jonker, J. W. Relat, J. Front Endocrinol (Lausanne) Endocrinology Frontiers Media S.A. 2023-08-07 /pmc/articles/PMC10441540/ /pubmed/37608789 http://dx.doi.org/10.3389/fendo.2023.1253675 Text en Copyright © 2023 De Sousa-Coelho, Rodriguez-Rodriguez, Softic, Jonker and Relat https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Endocrinology De Sousa-Coelho, A. L. Rodriguez-Rodriguez, R. Softic, S. Jonker, J. W. Relat, J. Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans |
| title | Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans |
| title_full | Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans |
| title_fullStr | Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans |
| title_full_unstemmed | Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans |
| title_short | Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans |
| title_sort | editorial: fgf21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans |
| topic | Endocrinology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441540/ https://www.ncbi.nlm.nih.gov/pubmed/37608789 http://dx.doi.org/10.3389/fendo.2023.1253675 |
| work_keys_str_mv | AT desousacoelhoal editorialfgf21asatherapeutictargetforobesityandinsulinresistancefromrodentmodelstohumans AT rodriguezrodriguezr editorialfgf21asatherapeutictargetforobesityandinsulinresistancefromrodentmodelstohumans AT softics editorialfgf21asatherapeutictargetforobesityandinsulinresistancefromrodentmodelstohumans AT jonkerjw editorialfgf21asatherapeutictargetforobesityandinsulinresistancefromrodentmodelstohumans AT relatj editorialfgf21asatherapeutictargetforobesityandinsulinresistancefromrodentmodelstohumans |